Guru Ownership Trend
Guru Analysis for Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $153.52 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $15.15 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Recursion Pharmaceuticals, Inc. (RXRX)
Major holders include Catherine Wood ($123.45 M), Renaissance Technologies (RenTech) ($7.37 M), Paul Tudor Jones ($814,459). According to the latest reported data, 4 tracked investment managers collectively hold approximately 43.12 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $15.15 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited RXRX. The total reported sell value was $2.68 M.
Yes, 3 managers opened new positions in RXRX, and 1 increased their existing holdings. The total reported buy value was $17.83 M.